1.For the first time we included human capital in company assets. We established an innovative benefit distribution model based on valuation.
2.By improving the coagulation process, we optimized the production of Fetal bovine serum (Product No.: RY-F22), which can now formulate optimal medium supporting the stable growth of cells.
3.We established the method detecting residual antibiotics in Bovine Serum.